MyFinsight
Home
About
Contact
akba: the income statement
Download
Download image
Japan Tobacco
Incorporation And Torii...
$1,494K
Mitsubishi Tanabe Pharma
Corporation
$455K
MEDICEArzneimittel Putter Gmb HCo KG
$28K
Auryxia
$42,467K
Vafseo
$14,322K
License Collaboration
And Other Revenue
$1,977K
Product
$56,789K
Total revenues
$58,766K
(57.01%↑ Y/Y)
Change in fair value of
warrant liability
-$1,464K
(-271.03%↓ Y/Y)
Income (loss) from
operations
$4,449K
(135.58%↑ Y/Y)
Total operating
expenses
$44,934K
(25.61%↑ Y/Y)
Total cost of goods
sold
$9,383K
(-33.74%↓ Y/Y)
Income (loss) before
income taxes
$1,155K
(105.76%↑ Y/Y)
Other income
(expense)
-$10K
(41.18%↑ Y/Y)
Interest expense
-$4,748K
(28.72%↑ Y/Y)
License
$896K
(16.51%↑ Y/Y)
Selling, general and
administrative
$29,094K
(9.72%↑ Y/Y)
Research and development
$14,944K
(76.08%↑ Y/Y)
Cost of product and
other revenue
$9,383K
(82.19%↑ Y/Y)
Net income (loss)
$540K
Income tax expense
$615K
Comprehensive income (loss)
$540K
Back
Back
Income Statement
source: myfinsight.com
Akebia Therapeutics, Inc. (AKBA)
Akebia Therapeutics, Inc. (AKBA)